Additive Effects of Pravastatin and Valsartan

NCT01004237 Phase 4 COMPLETED

The investigators hypothesize that pravastatin combined with valsartan may have additive effects in hypertensive, hypercholesterolemic patients.

Details

Lead sponsor	Gachon University Gil Medical Center
Phase	Phase 4
Status	COMPLETED
Enrolment	52
Start date	2009-11
Completion	2012-04

Conditions

• Hypertension
• High Cholesterol

Interventions

• pravastatin, valsartan, pravastatin+valsartan

Primary outcomes

• flow-mediated dilation — 8 weeks of treatment

Countries

South Korea